Clemmensen P
Department of Medicine B, Rigshospitalet, Copenhagen.
Dan Med Bull. 1996 Feb;43(1):68-85.
The present thesis is based on 6 previously published clinical studies in patients with AMI. Thrombolytic therapy for patients with AMI improves early infarct coronary artery patency, limits AMI size, improves left ventricular function and survival, as demonstrated in large placebo-controlled clinical trials. With the advent of interventions aimed at limiting AMI size it became important to assess the amount of ischemic myocardium in the early phase of AMI, and to develop noninvasive methods for evaluation of these therapies. The aims of the present studies were to develop such methods. The studies have included 267 patients with AMI admitted up to 12 hours after onset of symptoms. All included patients had acute ECG ST-segment changes indicating subepicardial ischemia, and patients with bundle branch block were excluded. Serial ECG's were analyzed with quantitative ST-segment measurements in the acute phase and compared to the Selvester QRS score estimated final AMI size. These ECG indices were compared to and validated through comparisons with other independent noninvasive and invasive methods, used for the purpose of evaluating patients with AMI treated with thrombolytic therapy. It was found that in patients with first AMI not treated with reperfusion therapies the QRS score estimated final AMI size can be predicted from the acute ST-segment elevation. Based on the number of ECG leads with ST-segment elevation and its summated magnitude, formulas were developed to provide an "ST score" for estimating the amount of myocardium in jeopardy during the early phase of AMI. The ST-segment deviation present in the ECG in patients with documented occlusion of the infarct related coronary artery, was subsequently shown to correlate with the degree of regional and global left ventricular dysfunction. Because serial changes in ST-segment elevation, during the acute phase of AMI were believed to reflect changes is myocardial ischemia and thus possibly infarct artery patency status, the summated ST-segment elevation present on the admission ECG was compared to that present after administration of intravenous thrombolytic therapy, and immediately prior to angiographic visualization of the infarct related coronary artery. The entire spectrum of sensitivities and specificities, derived from different cut-off values for the degree of ST-segment normalization, was described for the first time. It was found that a 20% decrease in ST-segment elevation could predict coronary artery patency with a high level of accuracy: positive predictive value = 88% and negative predictive value = 80%.(ABSTRACT TRUNCATED)
本论文基于6项先前发表的关于急性心肌梗死(AMI)患者的临床研究。如大型安慰剂对照临床试验所示,AMI患者的溶栓治疗可改善早期梗死冠状动脉通畅情况,限制AMI面积,改善左心室功能并提高生存率。随着旨在限制AMI面积的干预措施的出现,在AMI早期评估缺血心肌量并开发评估这些治疗方法的非侵入性手段变得至关重要。本研究的目的就是开发此类方法。这些研究纳入了267例症状发作后12小时内入院的AMI患者。所有纳入患者均有提示心外膜下缺血的急性心电图ST段改变,束支传导阻滞患者被排除。急性期通过定量ST段测量对系列心电图进行分析,并与估计最终AMI面积的塞尔维斯特QRS评分进行比较。将这些心电图指标与用于评估接受溶栓治疗的AMI患者的其他独立非侵入性和侵入性方法进行比较并验证。结果发现,在未接受再灌注治疗的首次AMI患者中,可根据急性ST段抬高预测QRS评分所估计的最终AMI面积。基于ST段抬高的心电图导联数量及其总和幅度,开发了公式以提供“ST评分”,用于估计AMI早期处于危险中的心肌量。随后发现,梗死相关冠状动脉闭塞患者心电图中出现的ST段偏移与局部和整体左心室功能障碍程度相关。由于AMI急性期ST段抬高的系列变化被认为反映心肌缺血变化,进而可能反映梗死动脉通畅状态,因此将入院心电图上的ST段抬高总和与静脉溶栓治疗后以及梗死相关冠状动脉造影可视化之前的ST段抬高总和进行比较。首次描述了源自ST段正常化程度不同临界值的敏感性和特异性的全谱。结果发现,ST段抬高降低20%可高度准确地预测冠状动脉通畅情况:阳性预测值 = 88%,阴性预测值 = 80%。(摘要截选)